Skip to main content
. 2017 Jan 11;8(4):2652–2660. doi: 10.1039/c6sc05059j

Fig. 6. Urinary albumin excretion (a, ***P < 0.001), protein excretion (b, ***P < 0.001) and clearance half-life of ABZWCY-HPβCD (c, **P < 0.01) in wild-type rats and AT1R transgenic rats. Elimination curves of ABZWCY-HPβCD by transcutaneous measurements in wild-type rats (d) and AT1R transgenic rats (e).

Fig. 6